Association of calcaneal quantitative ultrasound parameters with metabolic syndrome in middle-aged and elderly Chinese: a large population-based cross-sectional study

BMC Endocrine Disorders

Tao Yang¹  Wei He¹  Xiaoping Huang¹  Wei Tang¹  Yu Duan¹  Yun Shi¹  Jia Mao¹  Chuchen Meng¹  Zhenxin Zhu¹  Qi Fu¹  Mengdie Cao¹  Min Sun¹ 

[1] Department of Endocrinology, First Affiliated Hospital of Nanjing Medical University, 300 Guangzhou Road, Nanjing, Jiangsu 210029, China

关键词: Fragile fractures;    Calcaneal quantitative ultrasound;    Osteoporosis;    Metabolic syndrome;   

Others  :  1085225
DOI  :  10.1186/1472-6823-14-14

 received in 2012-11-12, accepted in 2014-02-11,  发布年份 2014

【 摘 要 】

Background

The possible association between metabolic syndrome (MS) and bone mineral density (BMD) has been highlighted recently. However, the exact effects of MS on calcaneal quantitative ultrasound (QUS) parameters remains uncertain. The aim of this study was to assess the impact of MS states, different componets of MS, as well as the number of MS componets on QUS.

Methods

A total of 7489 Chinese adults aged 40 years or older in Nanjing were enrolled in this cross-sectional study. MS was defined according to recommendations generated by the International Diabetes Federation (IDF) in 2005. QUS was measured for each participant.

Results

The prevalence of MS was 34.6% in men and 42.8% in women (over 40 years old). In postmenopausal women with MS, 25-hydroxyvitamin D[25(OH)D], age adjusted quantitative ultrasound index (QUI) and broadband ultrasound attenuation (BUA) were all lower than those without (p < 0.001, p = 0.023, p = 0.021, respectively), the difference of QUI and BUA disappeared after adjustment for body mass index (BMI) and waist circumference (WC). In stepwise analysis, BMI, WC, high density lipoprotein cholesterol (HDL-C) and fasting plasma glucose (FPG) were related to QUS (p < 0.05). The number of MS components had no influence on QUS. Fragile fracture incidence was higher in women with MS (6.8% VS. 5.3%, P = 0.034).

Conclusion

Chinese postmenopausal women with MS have worse BMD measured by QUS and more chances to develop osteoporotic fractures than the controls, which partially due to central obesity as well as vitamin D deficiency. People having less central obesity, higher FPG or HDL-C are less likely to have bone mineral loss.

【 授权许可】

   
2014 Sun et al.; licensee BioMed Central Ltd.

【 参考文献 】

• [1]Isomaa B, Almgren P, Tuomi T, Forsén B, Lahti K, Nissén M, Taskinen MR, Groop L: Cardiovascular morbidity and mortality associated with the metabolic syndrome. Diabetes Care 2001, 24:683-689.
• [2]Cho LW: Metabolic syndrome. Singapore Med J 2011, 52:779-785.
• [3]Sumner AD, Khalil YK, Reed JF III: The relationship of peripheral arterial disease and metabolic syndrome prevalence in asymptomatic US adults 40 years and older: results from the national health and nutrition examination survey (1999–2004). J Clin Hypertens 2012, 14:144-148.
• [4]Jia WP, Xiang KS: Current studies on new parameters of metabolic syndrome. Zhongguo Yi XueKeXue Yuan XueBao 2006, 28:737-739.
• [5]NIH Consensus Development Panel on Osteoporosis Prevention, Diagnosis, and Therapy: Osteoporosis prevention, diagnosis, and therapy. JAMA 2001, 285:785-795.
• [6]Li N, Ou P, Zhu H, Yang D, Zheng P: Prevalence rate of osteoporosis in the mid-aged and elderly in selected parts of China. Chin Med J 2002, 115:773-775.
• [7]Hwang DK, Choi HJ: The relationship between low bone mass and metabolic syndrome in Korean women. Osteoporos Int 2010, 21:425-431.
• [8]Yaturu S, Humphrey S, Landry C, Jain SK: Decreased bone mineral density in men with metabolic syndrome alone and with type 2 diabetes. Med SciMonit 2009, 15:CR5-CR9.
• [9]Yamaguchi T, Kanazawa I, Yamamoto M, Kurioka S, Yamauchi M, Yano S, Sugimoto T: Associations between components of the metabolic syndrome versus bone mineral density and vertebralfractures in patients with type 2 diabetes. Bone 2009, 45:174-179.
• [10]Ahmed LA, Schirmer H, Berntsen GK, Fonnebo V, Joakimsen RM: Features of the metabolic syndrome and the risk of non-vertebral fractures: the tromso study. Osteoporos Int 2006, 17:426-432.
• [11]Krieg MA, Barkmann R, Gonnelli S, Stewart A, Bauer DC, Del Rio Barquero L, Kaufman JJ, Lorenc R, Miller PD, Olszynski WP, Poiana C, Schott AM, Lewiecki EM, Hans D: Quantitative ultrasound in the management of osteoporosis: the ISCD official positions. J Clin Densitom 2007, 2008(11):163-187.
• [12]Glüer CC, Eastell R, Reid DM, Felsenberg D, Roux C, Barkmann R, Timm W, Blenk T, Armbrecht G, Stewart A, Clowes J, Thomasius FE, Kolta S: Association of five quantitative ultrasound devices and bone densitometry with osteoporotic vertebral fractures in a population-based sample: the OPUS Study. J Bone Miner Res 2004, 19:782-793.
• [13]Hernández JL, Olmos JM, de Juan J, Martínez J, Ramos C, Valero C, Nan D, González-Macías J: Heel quantitative ultrasound parameters in subjects with the metabolicsyndrome: the camargo cohort study. Maturitas 2011, 69:162-167.
• [14]Tseng YH, Huang KC, Liu ML, Shu WT, Sheu WH: Association between metabolic syndrome (MS) and bone mineral loss:a cross-sectional study in puli township in Taiwan. Arch Gerontol Geriatr 2009, 49:S37-S40.
• [15]Bulló M, Garcia-Aloy M, Basora J, Covas MI, Salas-Salvado J: Bone quantitative ultrasound measurements in relation to the metabolic syndrome and type 2 diabetes mellitus in a cohort of elderly subjects at high risk of cardiovascular disease from the PREDIMED study. J Nutr Health Aging 2011, 15:939-944.
• [16]Cvijetic S, Pavlovic M, Pasalic D, Dodig S: Ultrasound bone measurement in an older population with metabolic syndrome. Aging ClinExp Res 2011, 23:29-34.
• [17]Kim HY, Choe JW, Kim HK, Bae SJ, Kim BJ, Lee SH, Koh JM, Han KO, Park HM, Kim GS: Negative association between metabolic syndrome and bone mineral density in Koreans, especially in men. Calcif Tissue Int 2010, 86:350-358.
• [18]Boyanov M, Bakalov D, Boneva Z: Bone mineral density in men with and without the metabolic syndrome. Aging Male 2009, 12:62-65.
• [19]Migliaccio S, Greco EA, Fornari R, Donini LM, Lenzi A: Is obesity in women protective against osteoporosis? Diabetes Metab Syndr Obes 2011, 4:273-282.
• [20]Zhao LJ, Jiang H, Papasian CJ, Maulik D, Drees B, Hamilton J, Deng HW: Correlation of obesity and osteoporosis: effect of fat mass on the determination of osteoporosis. J Bone Miner Res 2008, 23:17-29.
• [21]Baz-Hecht M, Goldfine AB: The impact of vitamin D deficiency on diabetes and cardiovascular risk. Curr Opin Endocrinol Diabetes Obes 2010, 17:113-119.
• [22]Swales HH, Wang TJ: Vitamin D and cardiovascular disease risk: emerging evidence. Curr Opin Cardiol 2010, 25:513-517.
• [23]Gagnon C, Lu ZX, Magliano DJ, Dunstan DW, Shaw JE, Zimmet PZ, Sikaris K, Ebeling PR, Daly RM: Low serum 25-hydroxyvitamin D is associated with increased risk of the development of the metabolic syndrome at five years: results from a national, population-based prospective study. J Clin Endocrinol Metab 2012, 97:1953-1961.
• [24]Maki KC, Fulgoni VL 3rd, Keast DR, Rains TM, Park KM, Rubin MR: Vitamin D intake and status are associated with lower prevalence of metabolic syndrome in U.S. Adults: national health and nutrition examination surveys 2003–2006. Metab Syndr Relat Disord 2012, 10:363-372.
• [25]Sauque-Reyna L, Salcedo-Parra MA, Sánchez-Vargas PR, Flores-Helguera JD, Badillo-Sánchez C, Reza-Albarrán A, Rodríguez-Morán M, Guerrero-Romero F: Bone mineral density in patients with type 2 diabetes. Rev Invest Clin 2011, 63:162-169.
• [26]Hamann C, Kirschner S, Günther KP, Hofbauer LC: Bone, sweet bone-osteoporotic fractures in diabetes mellitus. Nat Rev Endocrinol 2012, 8:297-305.
• [27]Jeon YK, Lee JG, Kim SS, Kim BH, Kim YK, Kim IJ: Association between bone mineral density and metabolic syndrome in pre- and postmenopausal women. Endocr J 2011, 58:87-93.
• [28]Buizert PJ, van NM S, Lips P, Deeg DJH, Eekhoff EM: Lipid levels: a link between cardiovascular disease and osteoporosis? J Bone Miner Res 2009, 24:1103-1109.
• [29]Arikan DC, Coskun A, Ozer A, Kilinc M, Atalay F, Arikan T: Plasma selenium, zinc, copper and lipid levels in postmenopausal Turkish women and their relation with osteoporosis. Biol Trace Elem Res 2011, 144:407-417.
• [30]Von Muhlen D, Safii S, Jassal SK, Svartberg J, Barrett-Connor E: Associations between the metabolic syndrome and bone health in older men and women: the rancho bernardo study. Osteoporos Int 2007, 18:1337-1344.
• [31]Kinjo M, Setoguchi S, Solomon DH: Bone mineral density in adults with the metabolic syndrome: analysis in a population-based U.S. sample. J Clin Endocrinol Metab 2007, 92:4161-4164.
• [32]Shen C, Deng J, Zhou R, Chen J, Fan S, Li Z, Hu Y, Zhong Q: Relation between bone mineral density, bone loss and the risk of cardiovascular disease in a Chinese cohort. Am J Cardiol 2012, 110:1138-1142.
• [33]Ganesan K, Teklehaimanot S, Tran TH, Asuncion M, Norris K: Relationship of C-reactive protein and bone mineral density in community-dwelling elderly females. J Natl Med Assoc 2005, 97:329-333.
• [34]Tao B, Liu JM, Li XY, Wang JG, Wang WQ, Ning G: An assessment of the use of quantitative ultrasound and the osteoporosis self-assessment tool for Asians in determining the risk of nonvertebral fracture in postmenopausal Chinese women. J Bone Miner Metab 2008, 26:60-65.
• [35]Njeh CF, Hans D, Li J, Fan B, Fuerst T, He YQ, Tsuda-Futami E, Lu Y, Wu CY, Genant HK: Comparison of six calcaneal quantitative ultrasound devices: precision and hip fracture discrimination. Osteoporos Int 2000, 11:1051-1062.